CTLA4 and anemia: Ranking profiles of s‐AEs (Table 3) suggested that the addition of PD‐L1 and CTLA‐4 to EP had the lowest probability of vomiting (probability 35%), anemia (33%), neutrophil (11%), and dyspnea (29%).